Another China Player To Watch? Sinocare Moves Into US Via Nipro Deal
This article was originally published in PharmAsia News
Sinocare Group, a Chinese specialist in biosensor-based blood glucose monitoring devices, is expanding into the US market after agreeing to buy Nipro’s diabetes business, Nipro Diagnostics.
Register for our free email digests: